돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1746143생성일: 2026년 10월 27일

Hydrazine → Oxadiazole

https://huagongshe.com/reaction/1746143

반응식

참여 물질

역할이름HCID투입량
반응물HydrazineHCID 9321—
반응물Ethyl orthoformateHCID 31214—
반응물Methyl 5-hydroxypyridine-3-carboxylateHCID 354317—
반응물3-Bromo-1,2-oxazoleHCID 13933891—
용매MethanolHCID 887—
용매WaterHCID 962—
용매Ethyl AcetateHCID 8857—
생성물OxadiazoleHCID 10197612—
생성물3-(Pyridin-3-yloxy)-4,5-dihydroisoxazoleHCID 66818532—

반응 단계

3-(pyridin-3-yloxy)-4,5-dihydroisoxazole I-228a and I-228b were prepared in 3 steps according to the following procedures: 5-hydroxynicotinic acid methyl ester is reacted with racemic bromoisoxazole I-75 using Method 5. The resulting methyl ester (1.0 equiv) is dissolved in methanol (0.08 M) after which hydrazine (50 equiv, 50% by weight in water) is added and the reaction is allowed to stir for 14 h. The reaction mixture is then concentrated under vacuum and used directly in the next step. Triethylorthoformate (8.0 equiv) is added and the reaction is sealed and heated to reflux for 14 h. The reaction is then transferred to a separatory funnel with excess ethyl acetate and water. The organic layer was washed water and brine, drive over sodium sulfate and concentrated under vacuum to provide crude material which was purified using flash silica gel chromatography (gradient ethyl acetate/hexanes) to provide the desired racemic oxadiazole I-228. These compounds can be separated using chiral HPLC methods known in the art. For example, see chiral HPLC Method disclosed herein. [M+H]+=407.5 m/z. Activity: A

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09149465B2
출처 데이터셋uspto-grants-2015_10
ORD IDord-ca6e29a8d6c749a7bc5a1dc6435a30d2
출처 메모uspto-grants-2015_10